Navigation
The Company
Our Science
mTOR Pathway
nab
Technology Platform
Publications and Abstracts
Our Medicine
Our Medicine
Advanced Malignant PEComa
Pipeline
Patients
Overview
Patient Advocacy
Contact Us
General Contact
For Healthcare Professionals
Careers
Archive: November 17, 2023
Home
2023
November
17
17
Nov
2023
Phase 2, Multicenter, Global, Open-Label Basket Trial of
nab
-Sirolimus for Patients With Inactivating Alterations in
TSC1
and
TSC2
(PRECISION 1)
0
1
November 17, 2023
Phase 2, Multicenter, Global, Open-Label Basket Trial of nab-Sirolimus for Patients With Inactivating Alterations in TSC1 and TSC2 (PRECISION 1)
November 17, 2023
17
Nov
2023
Response to Treatment With
nab
-Sirolimus Among Patients With Malignant PEComa of Uterine Origin: A Subanalysis From AMPECTÂ
0
0
November 17, 2023
Response to Treatment With nab-Sirolimus Among Patients With Malignant PEComa of Uterine Origin: A Subanalysis From AMPECTÂ
November 17, 2023
